Cardionet rises as analyst upgrades shares
Shares of CardioNet Inc., which have lost two-thirds of their value in the last year, advanced Tuesday after an analyst upgraded the heart device maker’s stock. Matt Dolan of Roth Capital Partners said reimbursement rates for procedures using CardioNet’s… Roth Capital Partners – Business – Stock – Investing – CardioNet
Read more on San Francisco Chronicle
Leave a Reply